NCCN Task Force Report: Bone Health in Cancer Care
Bone health and maintenance of bone integrity are important components of comprehensive cancer care. The NCCN convened a multidisciplinary task force on Bone Health in Cancer Care to discuss the progress made in assessing bone health; cancer therapy and bone loss; therapeutic strategies for maintaining bone health in patients with cancer; role of antiresorptive agents in preventing recurrences; pathophysiology of bone metastases and its complications; imaging and treatment of bone metastases; and safety and toxicity considerations while using antiresorptive agents. Although bone health is important in all areas of oncology, this task force report focuses on bone health and bone metastases in patients with breast and prostate cancer.
This educational program is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Upon completion of this activity, participants should be able to:
- Describe imaging techniques for screening and detection of bone loss in patients with cancer and surgical management of bone metastasis
- Identify the appropriate management strategy for treatment-induced bone loss and skeletal complications associated with breast and prostate cancer
- Discuss the safety concerns of bone modifying agents and guidelines related to management of associated toxicities
- Communicate with the patient the rationale for bone-modifying agent
- Establish goals of bone-modifying therapy with the patient
- 1.50 Participation
- 1.50 Nurse
- 1.50 Pharmacist
- 1.50 Physician